286 related articles for article (PubMed ID: 25958132)
1. Next generation sequencing in endocrine practice.
Forlenza GP; Calhoun A; Beckman KB; Halvorsen T; Hamdoun E; Zierhut H; Sarafoglou K; Polgreen LE; Miller BS; Nathan B; Petryk A
Mol Genet Metab; 2015; 115(2-3):61-71. PubMed ID: 25958132
[TBL] [Abstract][Full Text] [Related]
2. Search for Novel Mutational Targets in Human Endocrine Diseases.
Park SY; Seo MH; Lee S
Endocrinol Metab (Seoul); 2019 Mar; 34(1):23-28. PubMed ID: 30912335
[TBL] [Abstract][Full Text] [Related]
3. GENETICS IN ENDOCRINOLOGY: Genetic diagnosis of endocrine diseases by NGS: novel scenarios and unpredictable results and risks.
Persani L; de Filippis T; Colombo C; Gentilini D
Eur J Endocrinol; 2018 Sep; 179(3):R111-R123. PubMed ID: 29880707
[TBL] [Abstract][Full Text] [Related]
4. Identification of a molecular defect in a stillborn fetus with perinatal lethal hypophosphatasia using a disease-associated genome sequencing approach.
Olech EM; Zemojtel T; Sowińska-Seidler A; Mundlos S; Robinson PN; Karczewski M; Jamsheer A
Pol J Pathol; 2016 Mar; 67(1):78-83. PubMed ID: 27179278
[TBL] [Abstract][Full Text] [Related]
5. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
[TBL] [Abstract][Full Text] [Related]
6. Targeted 46-gene and clinical exome sequencing for mutations causing cardiomyopathies.
Waldmüller S; Schroeder C; Sturm M; Scheffold T; Imbrich K; Junker S; Frische C; Hofbeck M; Bauer P; Bonin M; Gawaz M; Gramlich M
Mol Cell Probes; 2015 Oct; 29(5):308-14. PubMed ID: 25979592
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of amplicon-based next-generation sequencing in cancer.
Chang F; Li MM
Cancer Genet; 2013 Dec; 206(12):413-9. PubMed ID: 24332266
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnosis of hypophosphatasia and differential diagnosis by targeted Next Generation Sequencing.
Taillandier A; Domingues C; De Cazanove C; Porquet-Bordes V; Monnot S; Kiffer-Moreira T; Rothenbuhler A; Guggenbuhl P; Cormier C; Baujat G; Debiais F; Capri Y; Cohen-Solal M; Parent P; Chiesa J; Dieux A; Petit F; Roume J; Isnard M; Cormier-Daire V; Linglart A; Millán JL; Salles JP; Muti C; Simon-Bouy B; Mornet E
Mol Genet Metab; 2015 Nov; 116(3):215-20. PubMed ID: 26432670
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing and its applications in molecular diagnostics.
Su Z; Ning B; Fang H; Hong H; Perkins R; Tong W; Shi L
Expert Rev Mol Diagn; 2011 Apr; 11(3):333-43. PubMed ID: 21463242
[TBL] [Abstract][Full Text] [Related]
10. Next-generation sequencing entering the clinical arena.
Haas J; Katus HA; Meder B
Mol Cell Probes; 2011; 25(5-6):206-11. PubMed ID: 21914469
[TBL] [Abstract][Full Text] [Related]
11. Next generation sequencing for disorders of sex development.
Tobias ES; McElreavey K
Endocr Dev; 2014; 27():53-62. PubMed ID: 25247644
[TBL] [Abstract][Full Text] [Related]
12. A practical guide to genetic testing in endocrinology.
Izatt L; Owens MM; Pierce H; Wilcox S; Park SM
Clin Endocrinol (Oxf); 2022 Oct; 97(4):388-399. PubMed ID: 34528717
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing: ready for the clinics?
Desai AN; Jere A
Clin Genet; 2012 Jun; 81(6):503-10. PubMed ID: 22375550
[TBL] [Abstract][Full Text] [Related]
14. Clinical application of next-generation sequencing for Mendelian diseases.
Jamuar SS; Tan EC
Hum Genomics; 2015 Jun; 9(1):10. PubMed ID: 26076878
[TBL] [Abstract][Full Text] [Related]
15. Clinical genetic testing in endocrinology: Current concepts and contemporary challenges.
Newey PJ
Clin Endocrinol (Oxf); 2019 Nov; 91(5):587-607. PubMed ID: 31254405
[TBL] [Abstract][Full Text] [Related]
16. Clinical validation of targeted next-generation sequencing for inherited disorders.
Yohe S; Hauge A; Bunjer K; Kemmer T; Bower M; Schomaker M; Onsongo G; Wilson J; Erdmann J; Zhou Y; Deshpande A; Spears MD; Beckman K; Silverstein KA; Thyagarajan B
Arch Pathol Lab Med; 2015 Feb; 139(2):204-10. PubMed ID: 25611102
[TBL] [Abstract][Full Text] [Related]
17. Lessons learned from gene identification studies in Mendelian epilepsy disorders.
Hardies K; Weckhuysen S; De Jonghe P; Suls A
Eur J Hum Genet; 2016 Jul; 24(7):961-7. PubMed ID: 26603999
[TBL] [Abstract][Full Text] [Related]
18. [Mutation analysis for two hypophosphatasia families with targeted next-generation sequencing].
Bai Y; Liu N; Yang J; Guo Y; Kong XD
Zhonghua Yi Xue Za Zhi; 2016 Dec; 96(46):3718-3723. PubMed ID: 27998428
[No Abstract] [Full Text] [Related]
19. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
20. Design of targeted, capture-based, next generation sequencing tests for precision cancer therapy.
Hagemann IS; Cottrell CE; Lockwood CM
Cancer Genet; 2013 Dec; 206(12):420-31. PubMed ID: 24388712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
